• 2002

Company Description

Ilypsa is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.

It discovers and develops renal care pharmaceutical products. It develops non-absorbed polymeric phosphate and potassium binder compounds to treat chronic kidney diseases. The company, formerly known as Symyx Therapeutics, Inc. was founded in 2002 and is based in Santa Clara, California.